FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Chromatographic Bioanalysis Guidance

FDA issues a guidance to make recommendations to sponsors, applicants, and contract research organizations on internal standard response variability i...

Human Drugs

Ex-FDAer Sherman Joins Aptinyx Board

Former FDA principal deputy commissioner Rachel Sherman joins Aptinyxs board of directors.

Human Drugs

Pediatric Labeling Changes for Sovaldi and Harvoni

FDA summarizes labeling changes to Gileads Solvadi and Harvoni to add pediatric dosage forms.

Human Drugs

FDA Warnings Yield Lower Chantix Use: Study

Researchers say early FDA drug safety communications on Pfizers Chantix led to reduced prescribing in the VA health system, leading to an estimated 45...

Human Drugs

Study Finds Better Adverse Events Filed by Consumers

An new study suggests that FDAs 2013 move to a consumer-friendly adverse event reporting form has contributed positively to both the quality and quant...

Federal Register

Info Collection Extension for ANADAs

Federal Register notice: FDA submits to OMB an information collection extension for Abbreviated New Animal Drug Applications.

Human Drugs

FDA Required Post-Market Studies Empty Threat: Professor

Canadian health professor Matthew Herder says FDAs power to withdraw a drug if its manufacturer fails to produce useful required post-approval studies...

FDA Warns Umbilical Cord Blood Firm

FDA warns Stemell about multiple violations in its production of umbilical cord and umbilical cord blood products.

Federal Register

Review Period Determined for Bevyxxa

Federal Register notice: FDA determines the regulatory review period for patent extension purposes for Millennium Pharmaceuticals Bevyxxa (betrixaban ...

Human Drugs

CDERs Temple Covers Individualization in Drug Development

CDER deputy center director for clinical science Robert Temple discusses the move by industry and the agency to the third age of drug development the...